Jennie Deem
Director, Regulatory | Clinical Trial Labeling
Indianapolis, IN, United States | Eli Lilly and Company
About
Jennie Deem is Director of Regulatory, Clinical Trial Labeling at Eli Lilly and Company. With 20 years of clinical drug development supporting phase I-IV global trials across multiple therapeutic areas, she has most recently provided innovative strategic, tactical and operational regulatory support for labeling of clinical trial supplies. Jennie is a member of the GCSG Regulatory Team, the chair of the Clinical Supplies Leadership Forum Regulatory Community of Practice, and led the Health Authority Engagement team for the TransCelerate eLabels initiative. Prior to Lilly, Jennie was a cardiovascular critical care nurse and a surgical oncology nurse/practice manager. In her spare time, Jennie loves hiking, gardening and supporting the arts as President of the Indianapolis Ballet Guild.
Contact
Location | Indianapolis, IN, United States |
Company | Eli Lilly and Company |
Position | Director, Regulatory | Clinical Trial Labeling |
jdeem@lilly.com |
Industry Related Information
Membership Segmentation | Pharma Biotech |
Areas of Expertise |
Quality / Regulatory Packaging / Labelling Clinical Supplies Management |
Your Conferences
View the conferences you have attended.